| 1 |
30426904 | Design, Synthesis and Evaluation of Novel 3/4-((Substituted benzamidophenoxy) methyl)-N-hydroxybenzamides/propenamides as Histone Deacetylase Inhibitors and Antitumor Agents. | 2019 |
1 |
| 2 |
30530749 | Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. | 2019 Jan 24 |
1 |
| 3 |
31267876 | Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents. | 2019 |
1 |
| 4 |
29607910 | Syntheses and Biological Evaluation of Novel Hydroxamic Acid Derivatives Containing Purine Moiety as Histone Deacetylase Inhibitors. | 2018 |
1 |
| 5 |
29667768 | Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. | 2018 Jun |
1 |
| 6 |
29807520 | Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis. | 2018 |
1 |
| 7 |
30209338 | Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. | 2018 Sep 12 |
2 |
| 8 |
28196602 | Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity. | 2017 Apr |
1 |
| 9 |
27069638 | Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells. | 2016 Apr |
1 |
| 10 |
27169369 | Discovery of N-hydroxy-4-(1H-indol-3-yl)butanamide as a histone deacetylase inhibitor. | 2016 |
1 |
| 11 |
27283986 | Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. | 2016 Jul 12 |
1 |
| 12 |
25473896 | HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. | 2015 Jan 20 |
6 |
| 13 |
26133355 | Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as histone deacetylase inhibitors and antitumor agents. | 2015 |
1 |
| 14 |
26497064 | Inhibition mechanism of SAHA in HDAC: a revisit. | 2015 Nov 28 |
1 |
| 15 |
24864038 | Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. | 2014 Jul 15 |
1 |
| 16 |
24886748 | Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. | 2014 May 15 |
1 |
| 17 |
22944197 | Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. | 2013 Nov |
1 |
| 18 |
24189584 | Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells. | 2013 Nov 28 |
2 |
| 19 |
19738609 | Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. | 2009 Oct 6 |
1 |
| 20 |
18834886 | An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1. | 2008 Nov |
1 |